Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study of oncRNA Stratification of Cancer by Size and Stage

NCT05833360 is registered in ClinicalTrials.gov with Exai Bio Inc. as lead sponsor.

NCT NCT05833360
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05833360 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study of oncRNA Stratification of Cancer by Size and Stage
Lead sponsor
Exai Bio Inc.
Phase
Observational
Overall status
Recruiting
Start date
July 14, 2023
Completion date
July 14, 2030
Enrollment
2,400 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cancer